IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)

Peer Review reports

Original Submission
20 Oct 2020	Submitted	Original manuscript
3 Mar 2021	Reviewed	Reviewer Report - Kirsty Loudon
8 Apr 2021	Author responded	Author comments - André Mouraux
Resubmission - Version 2
8 Apr 2021	Submitted	Manuscript version 2
Publishing
15 Apr 2021	Editorially accepted
17 Jun 2021	Article published	10.1186/s13063-021-05272-y

Back to article page